Advion Biosciences, an Ithaca, NY-based contract research organization, said this week it has signed an agreement to sell its Bioservices division to Quintiles for an undisclosed amount of cash.
The sale, which is expected to be completed in early November, will include Advion's SISCAPA assay services, Jay Johnson, Quintiles' senior director of corporate communication, told ProteoMonitor.
Financial terms of the agreement were not disclosed.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
